PMID: 26763537DOI: 10.1038/nrcardio.2015.208Jan 15, 2016Paper

Dyslipidaemia in 2015: Advances in treatment of dyslipidaemia

Nature Reviews. Cardiology
S M Grundy

Abstract

No abstract listed.

References

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials

Jan 13, 2015·Lancet·UNKNOWN Cholesterol Treatment Trialists' (CTT) CollaborationAnthony Keech

Efficacy and safety of alirocumab in reducing lipids and cardiovascular events

Mar 17, 2015·The New England Journal of Medicine·Jennifer G RobinsonUNKNOWN ODYSSEY LONG TERM Investigators

Efficacy and safety of evolocumab in reducing lipids and cardiovascular events

Mar 17, 2015·The New England Journal of Medicine·Marc S SabatineUNKNOWN Open-Label Study of Long-Term Evaluation against LDL Cholesterol (OSLER) Investigators

Proof That Lower Is Better--LDL Cholesterol and IMPROVE-IT

Jun 4, 2015·The New England Journal of Medicine·John A Jarcho, John F Keaney

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

Jun 4, 2015·The New England Journal of Medicine·Christopher P CannonUNKNOWN IMPROVE-IT Investigators

❮ Previous
Next ❯

Citations

Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders.

Jun 25, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Birgit WaltenbergerAtanas G Atanasov

Haplotypes on pig chromosome 3 distinguish metabolically healthy from unhealthy obese individuals

Jun 2, 2017·PloS One·Simona D FrederiksenMerete Fredholm

Reduction of LDL-C-related residual cardiovascular risk with ezetimibe: are mechanistic considerations warranted in practice?

May 20, 2017·European Heart Journal·Karin H Humphries, G B John Mancini

CRISPR system in filamentous fungi: Current achievements and future directions

Jun 20, 2017·Gene·Huaxiang DengYujie Cai

Anti-PCSK9 antibodies for hypercholesterolaemia: Overview of clinical data and implications for primary care

Jul 28, 2017·International Journal of Clinical Practice·Olivier S DescampsIoanna Gouni-Berthold

Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance.

Jul 11, 2020·Journal of Lipid Research·Rene C AdamViktoria Gusarova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Related Papers

Treatment of diabetic dyslipidaemia.

(opens in new tab)
Biochemical Society Transactions
M A Denke, S M Grundy

Treatment of dyslipidaemia in renal disease

(opens in new tab)
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
G Warwick, G Bircher

Dyslipidaemia in diabetes

(opens in new tab)
Clinical Evidence
Jigisha Patel
ContactHelpTerms Privacy Cookies
© 2022 Meta ULC. All rights reserved